Review
Contrast media in patients with kidney disease: An update
Ali Mehdi, MD, MEd, Jonathan J. Taliercio, DO and Georges Nakhoul, MD, MEd
Cleveland Clinic Journal of Medicine November 2020, 87 (11) 683-694; DOI: https://doi.org/10.3949/ccjm.87a.20015
Ali Mehdi
Department of Nephrology and Hypertension, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
Jonathan J. Taliercio
Medical Director, Cleveland Clinic West Dialysis Unit, Department of Nephrology and Hypertension, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
Georges Nakhoul
Director, Center for Chronic Kidney Disease, Department of Nephrology and Hypertension, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

ABSTRACT
Concern for contrast-induced acute kidney injury (CI-AKI) or nephrogenic systemic fibrosis may lead to withholding important studies from patients with kidney disease. However, the actual risk or even the existence of these conditions has recently been called into question. The truth probably lies somewhere in the middle.
Footnotes
The authors report no relevant financial relationships which, in the context of their contributions, could be perceived as a potential conflict of interest.
- Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.
REFERENCES
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- Chertow GM,
- Normand SLT,
- McNeil BJ
- ↵
- Davenport MS,
- Khalatbari S,
- Cohan RH,
- Dillman JR,
- Myles JD,
- Ellis JH
- ↵
- McDonald JS,
- McDonald RJ,
- Carter RE,
- Katzberg RW,
- Kallmes DF,
- Williamson EE
- ↵
- ↵
- ↵
- ↵
- Ghumman SS,
- Weinerman J,
- Khan A, et al
- ↵
- ↵
- ↵
- ↵
- Nijssen EC,
- Rennenberg RJ,
- Nelemans PJ, et al
- ↵
- Timal RJ,
- Kooiman J,
- Sijpkens YWJ, et al
- ↵
- ↵
- Berwanger O
- ↵
- Bargman JM,
- Thorpe KE,
- Churchill DN
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- Marckmann P,
- Skov L,
- Rossen K, et al
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- US Food and Drug Administration
- ↵
- European Medicines Agency
- ↵
- ACR Committee on Drugs and Contrast Media
- ↵
- ↵
- ↵
- Endrikat J,
- Dohanish S,
- Schleyer N,
- Schwenke S,
- Agarwal S,
- Balzer T
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- Balogh EP,
- Miller BT,
- Ball JR
- ↵
- Woolen SA,
- Shankar PR,
- Gagnier JJ,
- MacEachern MP,
- Singer L,
- Davenport MS
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- European Society of Urogenital Radiology
- ↵
- Zou Z,
- Zhang HL,
- Roditi GH,
- Leiner T,
- Kucharczyk W,
- Prince MR
- ↵
- Kanda T,
- Ishii K,
- Kawaguchi H,
- Kitajima K,
- Takenaka D
- ↵
- Kanda T,
- Fukusato T,
- Matsuda M, et al
- ↵
- ↵ACR-ASNR position statement on the use of gadolinium contrast agents. Created May 2016. Accessed September 29, 2020. https://icpme.us/2016ACR/ACR_ASNR_Position_Statement_on_the_Use_of_Gadolinium_Contrast_Agents.pdf
Log in using your username and password
Registration is Now Required for Free Access to CCJM Content
Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.
If you are using a mobile device, click on the settings icon to access the Register link.
In this issue
Cleveland Clinic Journal of Medicine
Vol. 87, Issue 11
1 Nov 2020
Contrast media in patients with kidney disease: An update
Ali Mehdi, Jonathan J. Taliercio, Georges Nakhoul
Cleveland Clinic Journal of Medicine Nov 2020, 87 (11) 683-694; DOI: 10.3949/ccjm.87a.20015
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.